EP1551418A4 - Composes de cetophosphonates substitues ayant une activite anabolisante sur les os - Google Patents
Composes de cetophosphonates substitues ayant une activite anabolisante sur les osInfo
- Publication number
- EP1551418A4 EP1551418A4 EP03752401A EP03752401A EP1551418A4 EP 1551418 A4 EP1551418 A4 EP 1551418A4 EP 03752401 A EP03752401 A EP 03752401A EP 03752401 A EP03752401 A EP 03752401A EP 1551418 A4 EP1551418 A4 EP 1551418A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- ketophosphonate
- substituted
- compounds
- bone anabolic
- anabolic activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000001195 anabolic effect Effects 0.000 title 1
- 210000000988 bone and bone Anatomy 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
- C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4015—Esters of acyclic unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4018—Esters of cycloaliphatic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41209102P | 2002-09-19 | 2002-09-19 | |
US412091P | 2002-09-19 | ||
PCT/US2003/029080 WO2004026315A1 (fr) | 2002-09-19 | 2003-09-18 | Composes de cetophosphonates substitues ayant une activite anabolisante sur les os |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1551418A1 EP1551418A1 (fr) | 2005-07-13 |
EP1551418A4 true EP1551418A4 (fr) | 2006-05-03 |
Family
ID=32030802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03752401A Withdrawn EP1551418A4 (fr) | 2002-09-19 | 2003-09-18 | Composes de cetophosphonates substitues ayant une activite anabolisante sur les os |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1551418A4 (fr) |
JP (1) | JP2006504697A (fr) |
AU (2) | AU2003299029A1 (fr) |
WO (2) | WO2004026245A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8466096B2 (en) | 2007-04-26 | 2013-06-18 | Afton Chemical Corporation | 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions |
US8524691B2 (en) | 2008-08-13 | 2013-09-03 | The Medicines Company | Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
WO2010054966A2 (fr) * | 2008-11-13 | 2010-05-20 | Basf Se | Composés de benzylidène comprenant des groupes phosphono |
EP2270021A1 (fr) | 2009-06-18 | 2011-01-05 | Centre National de la Recherche Scientifique | Synthons de phosphonates pour la synthèse de dérivés de phosphonates démontrant une meilleure biodisponibilité |
EP2816049B8 (fr) * | 2013-06-20 | 2018-07-11 | Ivoclar Vivadent AG | Acides ß-cétophosphoniques et matériaux dentaires à base de ceux-ci |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1372541A (en) * | 1971-07-14 | 1974-10-30 | Ici Ltd | Cyclopentane derivatives |
US3982016A (en) * | 1975-08-06 | 1976-09-21 | Pfizer Inc. | Bone deposition by 16-aryl-13,14-dihydro-PGE2 p-biphenyl esters |
EP0163270A2 (fr) * | 1984-05-23 | 1985-12-04 | Green Cross Corporation | Inhibiteur de la lipoxygénase |
WO1994019358A1 (fr) * | 1993-02-19 | 1994-09-01 | Symphar S.A. | Phosphonates substitues, procedes de preparation et compositions pharmaceutiques les contenant |
US5508273A (en) * | 1993-12-30 | 1996-04-16 | Ortho Pharmaceutical Corporation | Substituted phosphonic acids and derivatives useful in treating bone wasting diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0377894A (ja) * | 1989-08-18 | 1991-04-03 | Toray Ind Inc | メチレンジホスホン酸化合物 |
AU8495091A (en) * | 1990-08-21 | 1992-03-17 | Upjohn Company, The | Bisphosphonic acid derivatives as anti-arthritic agents |
-
2003
- 2003-09-18 WO PCT/US2003/029392 patent/WO2004026245A2/fr not_active Application Discontinuation
- 2003-09-18 EP EP03752401A patent/EP1551418A4/fr not_active Withdrawn
- 2003-09-18 AU AU2003299029A patent/AU2003299029A1/en not_active Abandoned
- 2003-09-18 WO PCT/US2003/029080 patent/WO2004026315A1/fr not_active Application Discontinuation
- 2003-09-18 AU AU2003270693A patent/AU2003270693A1/en not_active Abandoned
- 2003-09-18 JP JP2004537860A patent/JP2006504697A/ja active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1372541A (en) * | 1971-07-14 | 1974-10-30 | Ici Ltd | Cyclopentane derivatives |
US3982016A (en) * | 1975-08-06 | 1976-09-21 | Pfizer Inc. | Bone deposition by 16-aryl-13,14-dihydro-PGE2 p-biphenyl esters |
EP0163270A2 (fr) * | 1984-05-23 | 1985-12-04 | Green Cross Corporation | Inhibiteur de la lipoxygénase |
WO1994019358A1 (fr) * | 1993-02-19 | 1994-09-01 | Symphar S.A. | Phosphonates substitues, procedes de preparation et compositions pharmaceutiques les contenant |
US5508273A (en) * | 1993-12-30 | 1996-04-16 | Ortho Pharmaceutical Corporation | Substituted phosphonic acids and derivatives useful in treating bone wasting diseases |
Non-Patent Citations (4)
Title |
---|
GRECO M N ET AL: "Nonpeptide Inhibitors of Cathepsin G: Optimization of a Novel.beta.-Ketophosphonic Acid Lead by Structure-Based Drug Design", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 124, no. 15, 17 April 2002 (2002-04-17), pages 3810 - 3811, XP002231848, ISSN: 0002-7863 * |
SAKODA R. ET AL.: "Novel synthesis of alpha-acetylstyrylphosphonates", SYNTHESIS., no. 7, 1993, DE GEORG THIEME VERLAG, STUTTGART., pages 705 - 713, XP002371174 * |
SCHWENDER C F ET AL: "1-Naphthylmethylphosphonic acid derivatives as osteoclastic acid phosphatase inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 5, no. 16, 17 August 1995 (1995-08-17), pages 1801 - 1806, XP004135368, ISSN: 0960-894X * |
See also references of WO2004026315A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1551418A1 (fr) | 2005-07-13 |
WO2004026315A1 (fr) | 2004-04-01 |
JP2006504697A (ja) | 2006-02-09 |
AU2003270693A1 (en) | 2004-04-08 |
AU2003299029A8 (en) | 2004-04-08 |
WO2004026245A2 (fr) | 2004-04-01 |
WO2004026245A8 (fr) | 2004-07-22 |
WO2004026245A3 (fr) | 2004-06-10 |
AU2003299029A1 (en) | 2004-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1583763E (pt) | Derivados de benzoazolilpiperazina com actividade antagonista de vr1 | |
AU2003243150A8 (en) | Resorption-controllable medical implants | |
EP1558585A4 (fr) | Composes neurologiquement actifs | |
GB0209022D0 (en) | Compounds | |
AU2003215150A8 (en) | Therapeutic compounds | |
AU2003216859A8 (en) | Amidoacetonitrile compounds | |
EP1551418A4 (fr) | Composes de cetophosphonates substitues ayant une activite anabolisante sur les os | |
GB0216224D0 (en) | Compounds | |
GB0207323D0 (en) | Compounds | |
GB0216383D0 (en) | Compounds | |
GB0216379D0 (en) | Compounds | |
GB0212399D0 (en) | Compounds | |
GB0213122D0 (en) | Compounds | |
GB0208392D0 (en) | Therapeutic compounds | |
PL355466A1 (en) | Syringe for independent first aid purposes | |
GB2401049B (en) | Arrangement for sterilizing objects | |
GB0203811D0 (en) | Compounds | |
GB0211098D0 (en) | Medical compounds | |
HUP0200109D0 (en) | Compounds having pharmaceutical activity | |
HUP0204362D0 (en) | Compounds having pharmaceutical activity | |
GB0206981D0 (en) | Compounds | |
CA94978S (en) | Disinfectant cartridge | |
PL355086A3 (en) | Disinfectant | |
GB0201509D0 (en) | Therapeutic Compounds | |
GB0200136D0 (en) | Therapeutic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050419 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060322 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060623 |